Speakers
Agenda
Register
FAQ
Committee Co-Chairs
Pricing
Life Sciences Future – BioPharm
September 30 – October 2, 2020
Click to explore our featured speakers and represented organizations.
About the Event
Life Sciences Future – BioPharm will be held Wednesday, September 30 through Friday, October 2, 2020 using a robust web-based platform that includes both live and on-demand features. The conference will include the most popular event features and will focus on various topics within the biotechnology and pharmaceutical industries.
Click here to learn about the Life Sciences Future – BioPharm Planning Committees. Conference Chair: Rachael Bushey, Partner and Chair of the Health Sciences Department at Troutman Pepper LLP.
Keynote Speakers
Sessions featuring our Keynote Speakers will focus on major topics of impact and interest related to the biotechnology and pharmaceutical spaces.
Company Reverse Pitches
Attendees will learn how to approach and communicate with business development teams. Included are presentations from major biotech and pharmaceutical organizations about the technologies they are seeking and not seeking, and how to navigate the process.
Knowledge Bursts
Attend the Knowledge Burst sessions throughout the morning to hear from inspiring speakers on an array of topics to engage, inform and challenge your thinking. Knowledge Burst speakers will tell their stories to impart practical wisdom you can use to improve your business practices or to just stay informed!
Scientific Posters
The Scientific Poster session provides researchers the opportunity to present their latest findings on our robust, interactive platform. For only $50, create a video presentation, share your findings, and get your research in front of hundreds of eyes. This session also provides an opportunity for attendees to connect with industry leaders and learn about companies in the biopharm space.
PS: LSPA will assist with your video creation! No production experience necessary! We’ll guide you along to make it a simple, straightforward process.
Abstract and presentation window closed September 23, 2020.
Company Presentations
Company Presentations allow emerging companies who are in funding stages to present their current business objectives to create potential partnerships and collaborations, showcase technology, and make a pitch for investments.
Applications closed September 11, 2020.
Partnering & More
Make the most of your conference experience by using our partnering system to connect with other attendees and schedule one-on-one video meetings. Partnering is offered all three days from 8:00 am – 4:30 pm using the same system as last year.
Featured Speakers
Ambassador Deborah L. Birx, MD
White House Coronavirus Response Coordinator
David B. Nash, MD, MBA
Founding Dean Emeritus at Jefferson College of Population Health, Thomas Jefferson University
Michelle McMurry-Heath, MD, PhD
President and CEO, BIO
Stephen Pitt, PhD
Head of Johnson & Johnson Innovation, JLABS US North East
Janet Woodcock, MD
Director, Center for Drug Evaluation and Research (CDER), Food and Drug Administration (FDA)
Paul Larkin
Manager, IBD Ventures, Crohn’s & Colitis Foundation
Albert W. DeRitis
Assistant Clinical Professor, Drexel LeBow College of Business
Ben Doranz, PhD, MBA
President and CEO, Integral Molecular
Jim Fries
Jim Fries, CEO, RX-360
Anjali Kumar, PhD
External Innovation Search and Evaluation, Eastern US, Johnson & Johnson Innovation
Ian L. Valerio, MD, MS, MBA, FACS,
Commander, Medical Corps, US Navy
Plastic and Reconstructive Surgeon at Harvard Medical School and Massachusetts General Hospital
Marla A. Phillips, PhD
Director, Xavier Health, Xavier University
George Khalife
Vice President, Midwest U.S., Toronto Stock Exchange & TSX Venture Exchange
Susan Van Meter
Executive Director, AdvaMedDx
Stephen Yoder, MD, MBA
Vice President, Business Development, Taiho Oncology
Mike Krepps
Principal, BrightEdge Investments, American Cancer Society
Lisa Gonzalez
Chief Meditation Officer, Meditation4-Leadership
Michael Flaschen
Headquarters Transactions Group, Merck
Bruce Levine
Barbara and Edward Netter Professor in Cancer Gene Therapy at the University of Pennsylvania Perelman School of Medicine
Chris Garabedian
Chairman and CEO, Xontogeny
Mittie Doyle, MD, FACR
Vice President, Clinical Research and Therapeutic Area Strategy- Immunology, CSL Behring
Luis Jodar, MD
Chief Medical Officer for Vaccines Medical Development and Medical/Scientific Affairs, Pfizer
Eric B. Kmiec, PhD
Director, Gene Editing Institute, Helen F. Graham Cancer Center & Research Institute, ChristianaCare
Chris Sasiela, PhD, RAC
Senior Regulatory Specialist, Innovator Support Team Lead, SEED, Office of Extramural Research, NIH
Amy Manley
Head of Clinical and Medical Operations, Paratek Pharmaceuticals
Keith Mazza
Senior Director, Pfizer
Amy Manley
Head of Clinical and Medical Operations, Paratek Pharmaceuticals
Stephanie Read
Vice President, Corporate Strategy & Business Development, CSL Behring
THANK YOU TO OUR SPONSORS
CLICK HERE TO VIEW ALL SPONSORS
THANK YOU TO OUR DIVERSITY & INCLUSION SPONSORS
CLICK HERE TO VIEW ALL D&I SPONSORS
Questions?
Questions about the event? Please contact lifesciencesfuturehelp@gmail.com.
